Lineage Cell Therapeutics : FORM S-3-Registration Statements -March 10, 2024 at 04:43 am EDT
As filed with the Securities and Exchange Commission on March 7, 2024 Registration No. 333- UNITED STATES SECURITIES...
Source: marketscreener.com
Page 48 - Genentech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Genentech Today - Breaking & Trending Today
Lineage Cell Therapeutics : Annual report which provides a comprehensive overview of the company for the past year -March 10, 2024 at 04:43 am EDT
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ...
Source: marketscreener.com
NIH clinical trial conducted in part at Arkansas Children's produces first FDA-approved treatment for multiple severe food allergies | Regional News
A groundbreaking clinical trial sponsored and funded by the National Institutes of Health (NIH) and conducted in part at Arkansas Children's Hospital (ACH) unveiled a pioneering treatment helping children and
Source: magnoliareporter.com
Oregon toddler gets first-of-its-kind treatment for rare disease
Lily Ahrens was diagnosed with spinal muscular atrophy, also known as SMA. It's estimated there are more than 84,000 carriers for the genetic disease.
Source: kgw.com
Will 2024 Be Easier on the Eyes?
Longer-acting drugs, novel implants, and oral and topical agents that aim to solve the burden of frequent injections and office visits for retinal disease are on the horizon.
Source: medscape.com